← Leaderboards
Sophie M Lanzkron
Johns Hopkins University
$1,783,607
Attributed
$2,413,771
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $761K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,413,771 · 4
By mechanism
R01$761,028 · 1
R34$706,469 · 1
K23$700,650 · 1
R21$245,624 · 1
Top collaborators
- Lydia Pecker2 shared
- Julie Kanter1 shared
- Jane Little1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Lydia Pecker$1,946,939
- Richard D Semba$20,161,870
- Patricia J O'Campo$522,470
- Edgar Raymond Miller$10,285,998
- Michelle J Hindin$1,716,913
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaAdultAffectPhysiciansHydroxyureaProspectiveHematologistSickle CellHospitalizationCaringResearch PersonnelAdherence (Attribute)Clinical ResearchPreparationProviderPharmacy FacilityCompliance BehaviorInterestBaseHematologyLeadNational Heart, Lung, And Blood InstituteAttitudeGuidelines
Grant awards (10)
Hypoxemia with Sleep in Sickle Cell Anemia-Prevalence, Clinical and Cellular Impact & Response to Therapy: A Multi-Site Prospective Study Accessing New Collaborative Pathways$761,028
R01 · FY2025 · HL
Anti-Mullerian Hormone in the Female Participants of the Multi-Center Study of Hydroxyurea$122,812
R21 · FY2019 · HL · contact PI
Anti-Mullerian Hormone in the Female Participants of the Multi-Center Study of Hydroxyurea$122,812
R21 · FY2018 · HL · contact PI
Improving Access to Hydroxyurea for Adults with Sickle Cell Disease$350,842
R34 · FY2014 · HL · contact PI
Improving Access to Hydroxyurea for Adults with Sickle Cell Disease$355,627
R34 · FY2013 · HL · contact PI
Sickle Cell Disease: First steps toward understanding barriers to care for adults$140,130
K23 · FY2012 · HL · contact PI
Sickle Cell Disease: First steps toward understanding barriers to care for adults$140,130
K23 · FY2011 · HL · contact PI
Sickle Cell Disease: First steps toward understanding barriers to care for adults$140,130
K23 · FY2010 · HL · contact PI
Sickle Cell Disease: First steps toward understanding barriers to care for adults$140,130
K23 · FY2009 · HL · contact PI
Sickle Cell Disease: First steps toward understanding barriers to care for adults$140,130
K23 · FY2008 · HL · contact PI